•
Jun 30, 2016

EyePoint Pharmaceuticals Q4 2016 Earnings Report

Total Revenue
$304K
Previous year: $409K
-25.7%
EPS
-$1.9
Previous year: -$1.7
+11.8%
Gross Profit
-$3.8M
Previous year: -$2.79M
+36.2%
Cash and Equivalents
$15.3M
Previous year: $19.1M
-19.9%
Free Cash Flow
-$16.4M
Total Assets
$31.6M
Previous year: $32.4M
-2.3%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals